News
Solute carrier family 25 member 19 (SLC25A19) is a transporter protein of thiamine pyrophosphate across cellular membranes, which is needed as a cofactor for multiple metabolic enzymes and is ...
Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection ...
In early-stage HCC patients (BCLC 0 and A), CP mRNA was elevated in 67.9% of cases, outperforming AFP, which detected only 46 ...
Alcohol consumption poses a significant global health risk, contributing to numerous diseases and injuries, especially among ...
Strategic insight into the Liver Cancer Treatment Market reveals a high-growth opportunity, especially in Asia-Pacific, driven by a rising patient po ...
There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to ...
Helio Genomics ("Helio" or "the Company"), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, today showcased results from three cancer ...
Liver transplantation is the sole curative option for HCC, but new therapies prompt reconsideration of transplant timing and ...
Bayer announced today initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha radiopharmaceutical being developed to treat tumors expressing Glypican-3 ...
for the first-line treatment of adults with recurrent or metastatic nonkeratinizing nasopharyngeal carcinoma (NPC); or as a single agent, for the treatment of adults with metastatic ...
Shandong Key Laboratory of Glycoscience and Glycotherapeutics, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, P. R. China Key Laboratory of Marine Drugs, Ministry of ...
The diagnostic process for identifying papillary renal cell carcinoma will include a physical exam, thorough medical history, laboratory tests, and imaging studies. If your healthcare provider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results